Hormones Inflammation and Thrombosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.

Also called NCT01875185

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01875185
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01875185. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-12 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2018-05-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hormones Inflammation and Thrombosis
Acronym
HIT2
Condition
Acute Coronary Syndrome
Condition
Thrombosis
Intervention (Drug)
Aspirin 81 mg
Lead sponsor
Johns Hopkins University (class: other)

Record details

Record id
cardio:ct-nct01875185
Content hash
bc423fc5f6c76aa07aeb0a21b3cf713688e2cb4643881bb3184ff9707ad3af0d